Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA2 | P00918 | 6/20 | 1.00 |
| ▸ | CA1 | P00915 | 5/20 | 1.00 |
| ▸ | TRPA1 | O75762 | 1/20 | 0.57 |
| ▸ | DHODH | Q02127 | 1/20 | 0.55 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.55 |
| ▸ | MEN1 | O00255 | 1/20 | 0.55 |
| ▸ | HKDC1 | Q2TB90 | 1/20 | 0.55 |
| ▸ | CA12 | O43570 | 1/20 | 0.54 |
| ▸ | PTGS2 | P35354 | 1/20 | 0.54 |
| ▸ | CA9 | Q16790 | 1/20 | 0.54 |
| ▸ | GSK3B | P49841 | 1/20 | 0.50 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.50 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.50 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.50 |
| ▸ | DAO | P14920 | 1/20 | 0.48 |
| ▸ | TSHR | P16473 | 1/20 | 0.48 |
| ▸ | NAPRT | Q6XQN6 | 1/20 | 0.48 |
| ▸ | S100B | P04271 | 1/20 | 0.47 |
| ▸ | CES2 | O00748 | 1/20 | 0.47 |
| ▸ | CES1 | P23141 | 1/20 | 0.47 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL11027747 | 1.00 | CA2 (1.00) | CA2CA1TRPA1DHODHKMT2A | |
| Dimethylamine SCHEMBL9588512 | 0.93 | CA2 (0.87) | CA2CA1TRPA1DHODHKMT2A | |
| SCHEMBL31397773 | 0.92 | CA2 (0.86) | CA2CA1TRPA1DHODHKMT2A | |
| SCHEMBL15367735 | 0.92 | CA2 (0.86) | CA2CA1TRPA1DHODHKMT2A | |
| SCHEMBL13310205 | 0.92 | CA2 (0.86) | CA2CA1TRPA1DHODHKMT2A | |
| SCHEMBL11415363 | 0.90 | CA2 (0.81) | CA2CA1TRPA1DHODHKMT2A | |
| SCHEMBL11415359 | 0.90 | CA2 (0.81) | CA2CA1TRPA1DHODHKMT2A | |
| SCHEMBL10035474 | 0.89 | CA2 (0.80) | CA2CA1TRPA1DHODHKMT2A | |
| SCHEMBL15479475 | 0.89 | CA2 (0.79) | CA2CA1DHODHKMT2AMEN1 | |
| Diethylamine SCHEMBL10426405 | 0.87 | CA2 (0.77) | CA2CA1TRPA1DHODHKMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 32 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-107056622-A | A kind of method that antimony organic catalytic hydrogenation imines prepares benzylamine compound | 湖南大学 | 2017-08-18 | — | — | CN | claimed |
| EP-0207559-B1 | METHOD FOR COUPLING LIVING POLYMERS OBTAINED BY ANIONIC POLYMMERIZATION | ENIRICERCHE S.p.A. (IT) | 1990-09-26 | — | — | EP | claimed |
| EP-3049387-B1 | THERMOPLASTIC POLYMER COMPOSITION | MILLIKEN & CO (US) | 2020-11-11 | — | — | EP | disclosed |
| EP-3049387-B1 | THERMOPLASTIC POLYMER COMPOSITION | MILLIKEN & CO (US) | 2020-11-11 | — | — | EP | disclosed |
| CN-105764883-B | Thermoplastic polymer composition | 美利肯公司 | 2019-06-04 | — | — | CN | disclosed |
| WO-2018185675-A1 | SUBSTITUTED OXOAZETIDINE ANALOGUES AS ROR GAMMA MODULATORS | GLENMARK PHARMACEUTICALS S.A. (CH) | 2018-10-11 | — | — | WO | disclosed |
| EP-3049468-B1 | NUCLEATING AGENT FOR THERMOPLASTIC POLYMER COMPOSITION | MILLIKEN & CO (US) | 2018-06-06 | — | — | EP | disclosed |
| CN-105764971-B | Thermoplastic polymer composition | 美利肯公司 | 2018-04-06 | — | — | CN | disclosed |
| CN-105745264-B | Thermoplastic polymer composition | 美利肯公司 | 2018-03-13 | — | — | CN | disclosed |
| CN-105745189-B | Thermoplastic polymer composition | 美利肯公司 | 2017-11-21 | — | — | CN | disclosed |
| CN-107056622-A | A kind of method that antimony organic catalytic hydrogenation imines prepares benzylamine compound | 湖南大学 | 2017-08-18 | — | — | CN | disclosed |
| US-20150094406-A1 | THERMOPLASTIC POLYMER COMPOSITION | MILLIKEN & COMPANY | 2015-04-02 | — | — | US | disclosed |
| WO-2015042563-A1 | THERMOPLASTIC POLYMER COMPOSITION | MILLIKEN & COMPANY (US) | 2015-03-26 | — | — | WO | disclosed |
| WO-2015042565-A1 | THERMOPLASTIC POLYMER COMPOSITION | MILLIKEN & COMPANY (US) | 2015-03-26 | — | — | WO | disclosed |
| WO-2015042561-A1 | THERMOPLASTIC POLYMER COMPOSITION | MILLIKEN & COMPANY (US) | 2015-03-26 | — | — | WO | disclosed |
| US-20150087757-A1 | THERMOPLASTIC POLYMER COMPOSITION | MILLIKEN & COMPANY | 2015-03-26 | — | — | US | disclosed |
| US-20150087758-A1 | THERMOPLASTIC POLYMER COMPOSITION | MILLIKEN & COMPANY | 2015-03-26 | — | — | US | disclosed |
| US-20150087759-A1 | THERMOPLASTIC POLYMER COMPOSITION | MILLIKEN & COMPANY | 2015-03-26 | — | — | US | disclosed |
| WO-2015042562-A1 | THERMOPLASTIC POLYMER COMPOSITION | MILLIKEN & COMPANY (US) | 2015-03-26 | — | — | WO | disclosed |
| US-4433900-A | Permanent display liquid crystal device via voltage application | CANON KABUSHIKI KAISHA (JP) | 1984-02-28 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20150087757-A1 | THERMOPLASTIC POLYMER COMPOSITION | PARG, PUF60, MCM7 | CA2 4186/4885CA1 2742/4885TRPA1 2872/4885 |
| US-20150087758-A1 | THERMOPLASTIC POLYMER COMPOSITION | ERCC4, SMCHD1, XRCC5 | CA2 4035/4885CA1 2118/4885TRPA1 3153/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.